Research Paper Volume 15, Issue 15 pp 7811—7830
A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma
Figure 10. Assays validation for genes participating in model. mRNA expression, IHC, and qRT-PCR for CASP3 (A–C), GSDMA (D–F), IL18 (G–I), and PLCG1 (J–L). *P < 0.05; **P < 0.01; ***P < 0.001.